Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
作者信息
Hoffmann Alexander P, Besch Ashley L, Othus Megan, Morsink Linde M, Wood Brent L, Mielcarek Marco, Estey Elihu H, Appelbaum Frederick R, Walter Roland B
机构信息
Medical School, University of Washington, Seattle, WA, USA.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
出版信息
Bone Marrow Transplant. 2020 Mar;55(3):669-672. doi: 10.1038/s41409-019-0739-2. Epub 2019 Nov 4.
PMID:31685932
Abstract
摘要
Zotero 插件